133 related articles for article (PubMed ID: 9293904)
21. Both extraneuronal monoamine transporter and O(6)-methylguanine-DNA methyltransferase expression influence the antitumor efficacy of 2-chloroethyl-3-sarcosinamide- 1-nitrosourea in human tumor xenografts.
Chen ZP; Wang ZM; Carter CA; Alley MC; Mohr G; Panasci LC
J Pharmacol Exp Ther; 2001 Mar; 296(3):712-5. PubMed ID: 11181897
[TBL] [Abstract][Full Text] [Related]
22. Effects of streptozotocin/bis-chloroethylnitrosourea combination therapy on O6-methylguanine DNA methyltransferase activity and mRNA levels in HT-29 cells in vitro.
Pieper RO; Futscher BW; Dong Q; Erickson LC
Cancer Res; 1991 Mar; 51(6):1581-5. PubMed ID: 1825618
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells using O6-benzylguanine and temozolomide.
Reese JS; Davis BM; Liu L; Gerson SL
Clin Cancer Res; 1999 Jan; 5(1):163-9. PubMed ID: 9918215
[TBL] [Abstract][Full Text] [Related]
24. Differential sensitivity of human and mouse alkyltransferase to O6-benzylguanine using a transgenic model.
Liu L; Lee K; Wasan E; Gerson SL
Cancer Res; 1996 Apr; 56(8):1880-5. PubMed ID: 8620508
[TBL] [Abstract][Full Text] [Related]
25. A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines.
Richard E; Géronimi F; Lalanne M; Ged C; Redonnet-Vernhet I; Lamrissi-Garcia I; Gerson SL; de Verneuil H; Moreau-Gaudry F
J Gene Med; 2003 Sep; 5(9):737-47. PubMed ID: 12950064
[TBL] [Abstract][Full Text] [Related]
26. Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy.
Suzuki M; Sugimoto Y; Tsukahara S; Okochi E; Gottesman MM; Tsuruo T
Clin Cancer Res; 1997 Jun; 3(6):947-54. PubMed ID: 9815770
[TBL] [Abstract][Full Text] [Related]
27. Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbones.
Jansen M; Bardenheuer W; Sorg UR; Seeber S; Flasshove M; Moritz T
Eur J Haematol; 2001 Jul; 67(1):2-13. PubMed ID: 11553261
[TBL] [Abstract][Full Text] [Related]
28. Retrovirus-mediated transfer of the human O6-methylguanine-DNA methyltransferase gene into a murine hematopoietic stem cell line and resistance to the toxic effects of certain alkylating agents.
Wang G; Weiss C; Sheng P; Bresnick E
Biochem Pharmacol; 1996 May; 51(9):1221-8. PubMed ID: 8645346
[TBL] [Abstract][Full Text] [Related]
29. Hammerhead ribozyme-mediated sensitization of human tumor cells after treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Zhang Q; Ohannesian DW; Erickson LC
J Pharmacol Exp Ther; 2004 May; 309(2):506-14. PubMed ID: 14742745
[TBL] [Abstract][Full Text] [Related]
30. Human long-term culture initiating cells are sensitive to benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and protected after mutant (G156A) methylguanine methyltransferase gene transfer.
Koç ON; Reese JS; Szekely EM; Gerson SL
Cancer Gene Ther; 1999; 6(4):340-8. PubMed ID: 10419052
[TBL] [Abstract][Full Text] [Related]
31. [In vitro study on transduction of human O(6)-methylguanine-DNA-methyltransferase cDNA into human umbilical cord blood CD34(+) cells].
Wang J; Xia X; Chen Z; Lu D; Xue J; Ruan C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Dec; 17(6):395-8. PubMed ID: 11110975
[TBL] [Abstract][Full Text] [Related]
32. Collateral sensitivity to nitrosoureas in multidrug-resistant cells selected with verapamil.
Futscher BW; Campbell K; Dalton WS
Cancer Res; 1992 Sep; 52(18):5013-7. PubMed ID: 1387586
[TBL] [Abstract][Full Text] [Related]
33. Enhancing hemopoietic drug resistance: a rationale for reconsidering the clinical use of mitozolomide.
Fairbairn LJ; Chinnasamy N; Lashford LS; Chinnasamy D; Rafferty JA
Cancer Gene Ther; 2000 Feb; 7(2):233-9. PubMed ID: 10770631
[TBL] [Abstract][Full Text] [Related]
34. In vivo selection of human hematopoietic cells in a xenograft model using combined pharmacologic and genetic manipulations.
Pollok KE; Hartwell JR; Braber A; Cooper RJ; Jansen M; Ragg S; Bailey BJ; Erickson LC; Kreklau EL; Williams DA
Hum Gene Ther; 2003 Dec; 14(18):1703-14. PubMed ID: 14670122
[TBL] [Abstract][Full Text] [Related]
35. Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive O6-alkylguanine-DNA alkyltransferase and are sensitive to O6-benzylguanine plus BCNU.
Gerson SL; Phillips W; Kastan M; Dumenco LL; Donovan C
Blood; 1996 Sep; 88(5):1649-55. PubMed ID: 8781420
[TBL] [Abstract][Full Text] [Related]
36. In vivo effects of myeloablative alkylator therapy on survival and differentiation of MGMTP140K-transduced human G-CSF-mobilized peripheral blood cells.
Cai S; Hartwell JR; Cooper RJ; Juliar BE; Kreklau E; Abonour R; Goebel WS; Pollok KE
Mol Ther; 2006 May; 13(5):1016-26. PubMed ID: 16426896
[TBL] [Abstract][Full Text] [Related]
37. Modulation of 1,3-bis-(2-chloroethyl)-1-nitrosourea resistance in human tumor cells using hammerhead ribozymes designed to degrade O6-methylguanine DNA methyltransferase mRNA.
Zhang Q; Ohannesian DW; Kreklau EL; Erickson LC
J Pharmacol Exp Ther; 2001 Jul; 298(1):141-7. PubMed ID: 11408535
[TBL] [Abstract][Full Text] [Related]
38. Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells.
Allay JA; Galipeau J; Blakley RL; Sorrentino BP
Stem Cells; 1998; 16 Suppl 1():223-33. PubMed ID: 11012166
[TBL] [Abstract][Full Text] [Related]
39. In vivo methotrexate selection of murine hemopoietic cells transduced with a retroviral vector for Gaucher disease.
Havenga M; Valerio D; Hoogerbrugge P; Es H
Gene Ther; 1999 Oct; 6(10):1661-9. PubMed ID: 10516714
[TBL] [Abstract][Full Text] [Related]
40. Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities.
Hansen RJ; Nagasubramanian R; Delaney SM; Cherian MM; Lin S; Kogan SC; Dolan ME
J Pharmacol Exp Ther; 2005 Dec; 315(3):1247-55. PubMed ID: 16126841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
